University of Montpellier
Also known as: a-bourdin@chu-montpellier.fr | Centre hospitalier de Montpellier | Centre Val d'Aurelle Paul Lamarque-MONTPELLIER | Centre Val d'Aurel-Paul Lamarque-Montpellier | CHRU de Montpellier | CHRU Montpellier | CHRU Montpellier, France | CHU Arnaud de Villeneuve MONTPELLIER | CHU Arnaud de Villeneuve, Montpellier, France | Chu de Montpellier | CHU de Montpellier | CHU de Montpellier, France | CHU Montpellier | CHU Montpellier - Department of gynaecology and obstetric | CHU Montpellier, France | CHU Montpellier - Lapeyronie | CHU Montpellier - Saint-Eloi | CHU Montpellier - UFR Odontologie de Montpellier | CHU of Montpellier | CRLC Val d'Aurelle | CRLC Val d'Aurelle-Paul Lamarque | CRLC Val d'Aurelle Paul-Lamarque, Montpellier, France | Departement of Medical Imaging - Montpellier University hospital LAPEYRONIE Hospital | Department d'Anesthésie reanimation Lapeyronie | Department of Infectious and Tropical Diseases, CHU Montpellier | DRCI ICM VAL D'AURELLE | EHPAD "Les monts d'Aurelle",Parc Euromedecine 1632 Rue St Priest 34097 MONTPELLIER CEDEX 5 | EHPAD Malbosc, 345 Avenue de Fes 34090 MONTPELLIER | Faculté d'Odontologie, Université de Montpellier | Head of the Department of Anesthesiology and Critical Care Medicine of Lapeyronie University Hospital and Montpellier University, France | Hôpital Gui de Chauliac - University Hospital of Montpellier | Hopital Lapeyronie-CHU Montpellier | HOPITAL ST ELOI - MONTPELLIER CEDEX 5 | Hospital of Montpellier | ICM - Institut régional du Cancer Montpellier | ICM Val d'Aurelle | Infectious Diseases department of CHU-Montpellier | Insititut régional de Cancer de Montpellier | Institut du Cancer de Montpellier | Institut du Cancer de Montpellier (ICM) | Institut du Cancer de Montpellier - Val d'Aurelle | Institut du Cancer Montpellier | institut régional du Cancer de Montpellier | Institut régional du cancer de Montpellier | Institut régional du Cancer de Montpellier | Institut Régional du Cancer de Montpellier (ICM) | Institut regional du Cancer Montpellier | Institut régional du Cancer Montpellier | Institut Universitaire de Recherche Clinique Montpellier | IRD, Epidemiologie et Prevention, Montpelier, France | IRD, INSERM, University Montpellier | IRD, Montpelier | Laboratoire d'Informatique, de Robotique et de Microélectronique de Montpellier | Lapeyronie Montpellier University Hospital | Maison de Retraite Protestante, 2252 Rte de Mende 34090 MONTPELLIER | Médecine interne, Faculté de Montpellier | Montpellier (FR), Arnaud de Villeneuve Hospital | Montpellier University | Montpellier University, France | Montpellier university hospital | Montpellier University Hospital | MPEA2, Département Universitaire de Pédopsychiatrie, CHU de Montpellier | Pathogenesis and Control of Chronic Infections (PCCI) UMR 1058 - INSERM, Univ Montpellier, EFS, Montpellier, France | Philippe.Rouanet@icm.unicancer.fr | Saint Eloi Hospital | Saint Eloi Hospital - Montpellier University Hospital | UF of Montpellier | UH Montpellier | UHNIMES | UH of Montpellier | Unit Inserm U1061, Montpellier | Université Montpellier | University Hospital, Montpellier | University Hospital Montpellier France | University Hospitals of Monpellier | University Hospitals of Montpellier, France | University Hosptial of Montpellier | University of Montpellier (Faculté de Médecine) and Institute Sainte Catherine | University of Montpellier, France | University of Montpellier France; French Society of Dermatology; french group for study of blistering diseases | University of Montpellier Hospitals | Univerty Hospital Montpellier
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1996Last known activity
Jan 15, 2026
Timeline
1280s
- Jan 1, 1289
University of Montpellier— Founded
Drugs by trial phase (200 distinct, 181 trials)
Phase 4 (19 own, 0 via acquisition)
Phase 3 (77 own, 0 via acquisition)
Phase 2 (43 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Indications
Studied for
- Acidosis
- Acute Lung Injury
- Acute Pain
- Adenocarcinoma
- Adrenal Insufficiency
- Amyotrophic Lateral Sclerosis
- Anorexia
- Anorexia Nervosa
- Aortic Valve Stenosis
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Attention Deficit Disorder with Hyperactivity
- Back Pain
- Biliary Tract Neoplasms
- Brain Death
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Neoplasms
- Breast Neoplasms
- Brugada Syndrome
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Merkel Cell
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Transitional Cell
- Cholangiocarcinoma
- Colonic Neoplasms
- Colorectal Neoplasms
- Coronavirus Infections
- Diabetes Mellitus, Type 1
- Diabetic Foot
- Diabetic Nephropathies
- Diabetic Retinopathy
- Disorders of Excessive Somnolence
- Esophageal Neoplasms
- Fibrosis
- Foot Ulcer
- Graft vs Host Disease
- Head and Neck Neoplasms
- Heart Diseases
- Hemangioma
- Hemangioma, Capillary
- Hematoma
- Hematoma, Subdural
- Hematoma, Subdural, Chronic
- Hematoma, Subdural, Intracranial
- Hemophilia A
- Hemophilia B
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis C
- Herpes Genitalis
- HIV Infections
- Hyperkinesis
- Hypertension
- Hypertension, Pulmonary
- Idiopathic Hypersomnia
- Infarction
- Intervertebral Disc Degeneration
- Intervertebral Disc Displacement
- Kidney Diseases
- Kidney Neoplasms
- Liver Neoplasms
- Low Back Pain
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Medulloblastoma
- Melanoma
- Meningeal Carcinomatosis
- Meningitis
- Mesothelioma
- Motor Neuron Disease
- Myocardial Infarction
- Narcolepsy
- Neoplasm Metastasis
- Neoplasms
- Neoplastic Cells, Circulating
- Osteoarthritis
- Osteoporosis
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Pemphigoid, Bullous
- Peritoneal Neoplasms
- Pneumonia
- Pneumonia, Viral
- Port-Wine Stain
- Postpartum Hemorrhage
- Prostatic Neoplasms
- Psychomotor Agitation
- Pulmonary Disease, Chronic Obstructive
- Rectal Neoplasms
- Recurrence
- Renal Insufficiency, Chronic
Recent trials (50)
- NCT07028710OfficialN/AJan 15, 2026
- NCT07028710Lead sponsorN/AJan 15, 2026
- NCT07189325Lead sponsorPhase 3Sep 30, 2025
- NCT07013123Lead sponsorPhase 3Jul 15, 2025
- NCT07013123OfficialPhase 3Jul 15, 2025
- NCT06892951CollaboratorPhase 1/Phase 2Jun 30, 2025
- NCT06945848Lead sponsorN/AApr 30, 2025
- NCT06736483Lead sponsorPhase 2Jan 2, 2025
- NCT06263816CollaboratorPhase 3Nov 15, 2024
- NCT06590662OfficialPhase 2Sep 15, 2024
- NCT06590662Lead sponsorPhase 2Sep 15, 2024
- NCT06291012OfficialPhase 4Sep 1, 2024
- NCT06291012Lead sponsorPhase 4Sep 1, 2024
- NCT05924425Overall official - principal investigatorPhase 4Jul 1, 2023
- NCT05924425Lead sponsorPhase 4Jul 1, 2023
Details
- Founded
- Montpellier, FR Jan 1, 1289
- Last known activity
- Jan 15, 2026